SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-044231
Filing Date
2014-06-05
Accepted
2014-06-05 16:15:46
Documents
10
Period of Report
2014-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-14482_18k.htm 8-K 52910
2 EX-10.1 a14-14482_1ex10d1.htm EX-10.1 371086
3 EX-10.2 a14-14482_1ex10d2.htm EX-10.2 91508
4 EX-10.3 a14-14482_1ex10d3.htm EX-10.3 202232
5 EX-10.4 a14-14482_1ex10d4.htm EX-10.4 169525
6 EX-10.5 a14-14482_1ex10d5.htm EX-10.5 625264
7 EX-99.1 a14-14482_1ex99d1.htm EX-99.1 25120
8 EX-99.2 a14-14482_1ex99d2.htm EX-99.2 255147
9 GRAPHIC g144961mmi001.jpg GRAPHIC 3705
10 GRAPHIC g144961mmi002.jpg GRAPHIC 4971
  Complete submission text file 0001104659-14-044231.txt   1806496
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 14893860
SIC: 2834 Pharmaceutical Preparations